Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Fosgonimeton Phase 1 Trials M3 Biotechnology (later Athira Pharma) completes Phase 1 safety trials of fosgonimeton, a prodrug of Dihexa
Shaking introduces foam and can damage the peptide structure
Delivered intravenously, these nutrients reach your cells at concentrations oral supplements cannot achieve, supporting energy production, immune function, and cellular repair simultaneously
Verify current regulatory status, as it continues to evolve
Both options remain effective when used as directed
US$ 21.54
US$ 27.45
US$ 20.05
US$ 28.55
US$ 25.96
